We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$96.8B
AUM Growth
-$1.63B
Cap. Flow
-$6.28B
Cap. Flow %
-6.49%
Top 10 Hldgs %
7.41%
Holding
4,043
New
538
Increased
1,352
Reduced
1,501
Closed
517

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$735M
2
AAPL icon
Apple
AAPL
+$542M
3
MA icon
Mastercard
MA
+$523M
4
CRM icon
Salesforce
CRM
+$484M
5
PEP icon
PepsiCo
PEP
+$402M

Sector Composition

Rank Sector Weight
1 Technology 13.72%
2 Industrials 10.4%
3 Financials 10.22%
4 Healthcare 8.57%
5 Consumer Discretionary 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFCF icon
3101
Dimensional Core Fixed Income ETF
DFCF
$10.8B
$81.8K ﹤0.01%
+1,912
New +$81.1K
XBIT icon
3102
XBiotech
XBIT
$68.9M
$80.6K ﹤0.01%
30,317
-1,901
-6% -$5.63K
RDNW
3103
RideNow Group
RDNW
$251M
$80.5K ﹤0.01%
18,295
-4,368
-19% -$13.9K
VIOG icon
3104
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.05B
$79.9K ﹤0.01%
656
-75
-10% -$8.9K
ALK icon
3105
PUT
Alaska Air
ALK
$5.3B
$79.6K ﹤0.01%
1,600
CNTX icon
3106
Context Therapeutics
CNTX
$57.2M
$79.5K ﹤0.01%
82,111
-24,668
-23% -$20K
IP icon
3107
CALL
International Paper
IP
$22.5B
$78.9K ﹤0.01%
1,700
-700
-29% -$34.2K
INO icon
3108
Inovio Pharmaceuticals
INO
$79.4M
$78.4K ﹤0.01%
33,496
-81,668
-71% -$156K
ESGE icon
3109
iShares ESG Aware MSCI EM ETF
ESGE
$6.53B
$77.8K ﹤0.01%
1,791
-9,843
-85% -$402K
LODE icon
3110
Comstock
LODE
$236M
$77.5K ﹤0.01%
+22,671
New +$70.6K
FPH icon
3111
Five Point Holdings
FPH
$385M
$73.8K ﹤0.01%
12,046
-21,891
-65% -$127K
SERA icon
3112
Sera Prognostics
SERA
$80.3M
$73.7K ﹤0.01%
24,083
-9,299
-28% -$26.5K
CLYM
3113
Climb Bio
CLYM
$732M
$73.6K ﹤0.01%
36,602
+2,292
+7% +$4.26K
ARTV
3114
Artiva Biotherapeutics
ARTV
$501M
$73.3K ﹤0.01%
25,552
-13,140
-34% -$35.2K
PLRX icon
3115
Pliant Therapeutics
PLRX
$66.9M
$73.3K ﹤0.01%
49,515
-102,147
-67% -$156K
FMAT icon
3116
Fidelity MSCI Materials Index ETF
FMAT
$587M
$73K ﹤0.01%
1,393
-431
-24% -$22.4K
DXLG icon
3117
Destination XL Group
DXLG
$34.3M
$72.7K ﹤0.01%
55,517
-20,535
-27% -$26.9K
FALN icon
3118
iShares Fallen Angels USD Bond ETF
FALN
$1.63B
$71.3K ﹤0.01%
2,567
-6,836
-73% -$186K
JQUA icon
3119
JPMorgan US Quality Factor ETF
JQUA
$8.16B
$70.9K ﹤0.01%
1,127
-2,759
-71% -$169K
DTD icon
3120
WisdomTree US Total Dividend Fund
DTD
$1.65B
$70.7K ﹤0.01%
+842
New +$69K
QLD icon
3121
ProShares Ultra QQQ
QLD
$12.5B
$70.7K ﹤0.01%
+1,030
New +$64.8K
ENB icon
3122
PUT
Enbridge
ENB
$121B
$70.6K ﹤0.01%
1,400
+1,300
+1,300% +$61.2K
DD icon
3123
PUT
DuPont de Nemours
DD
$18.9B
$70.1K ﹤0.01%
717
+398
+125% +$37.5K
HOLO icon
3124
MicroCloud Hologram
HOLO
$37.8M
$70K ﹤0.01%
+14,198
New +$70.8K
TWNP
3125
DELISTED
Twin Hospitality Group
TWNP
$69.7K ﹤0.01%
16,718
-18,003
-52% -$72.7K

Similar funds

Qube Research & Technologies (QRT)'s Q3 2025 Portfolio in Review

As of Q3 2025, Qube Research & Technologies (QRT) held 4,043 positions worth $96.8B, down 1.7% from $98.4B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

Qube Research & Technologies (QRT) withdrew a net $6.28B in Q3 2025, closing 517 positions and reducing 1,501 holdings. Its most notable exit was Applovin, an estimated $390M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.

Against the trend, Qube Research & Technologies (QRT) opened a new position in Broadcom worth $754M.

  • Qube Research & Technologies (QRT)'s largest Q3 2025 buy was Broadcom: 2,284,316 shares worth $754M.
  • Qube Research & Technologies (QRT) added most to Microsoft in Q3 2025, an estimated $775M increase.
  • Qube Research & Technologies (QRT)'s biggest Q3 2025 reduction was Thermo Fisher Scientific, cutting an estimated $735M.
  • Qube Research & Technologies (QRT) fully exited Applovin in Q3 2025, selling an estimated $390M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 7.4% of its $96.8B portfolio in Q3 2025.
  • Qube Research & Technologies (QRT) opened 538 new positions and closed 517 in Q3 2025.
  • Qube Research & Technologies (QRT)'s portfolio value fell 1.7% quarter-over-quarter to $96.8B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.